Skip to content

Manel J. Barbanoj

15 papers in the library · 2,469 citations · publishing 2001-2012

Papers

Sort Most recent Most cited

Personality, Psychopathology, Life Attitudes and Neuropsychological Performance among Ritual Users of Ayahuasca: A Longitudinal Study

PLoS One August 8, 2012 José Carlos Bouso, Débora González, Sabela Fondevila et al. 313 citations

Ayahuasca is an Amazonian psychoactive plant beverage containing the serotonergic 5-HT(2A) agonist N,N-dimethyltryptamine (DMT) and monoamine oxidase-inhibiting alkaloids (harmine, harmaline and tetrahydroharmine) that render it orally active. Ayahuasca ingestion is a central feature in several Brazilian syncretic churches that have expanded their activities to urban Brazil, Europe and North...

DOI: 10.1371/journal.pone.0042421 (opens in new tab) Ayahuasca Psychopathology Hallucinogen Impulsivity +2

4-Bromo-2,5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effects.

Journal of Psychopharmacology July 1, 2012 Fernando Caudevilla-Gálligo, Jordi Riba, Mireia Ventura et al. 99 citations

4-Bromo-2,5-dimethoxyphenethylamine (2C-B) is a psychoactive analogue of mescaline that is becoming increasingly popular as a rave and club drug. We investigated its presence in the illicit drug market in Spain, its pattern of use and profile of subjective effects. Drug material was analysed for 2C-B and information on pattern of use and subjective effects was obtained from recreational users....

DOI: 10.1177/0269881111431752 (opens in new tab) Full text (opens in new tab) 2c-b drug Synthetic drug 2c-b 2c-b substance Drug trends +18

Autonomic, Neuroendocrine, and Immunological Effects of Ayahuasca

Journal of Clinical Psychopharmacology October 15, 2011 Rafael G. Dos Santos, Marta Valle, José Carlos Bouso et al. 136 citations

Ayahuasca is an Amazonian psychotropic plant tea combining the 5-HT2A agonist N,N-dimethyltryptamine (DMT) and monoamine oxidase-inhibiting β-carboline alkaloids that render DMT orally active. The tea, obtained from Banisteriopsis caapi and Psychotria viridis, has traditionally been used for religious, ritual, and medicinal purposes by the indigenous peoples of the region. More recently, the...

DOI: 10.1097/jcp.0b013e31823607f6 (opens in new tab) Ayahuasca Hallucinogen Pharmacology Amphetamine +2

Pharmacology of ayahuasca administered in two repeated doses

Psychopharmacology August 12, 2011 Rafael G. Dos Santos, Eva Grasa, Marta Valle et al. 139 citations

RationaleAyahuasca is an Amazonian tea containing the natural psychedelic 5-HT(2A/2C/1A) agonist N,N-dimethyltryptamine (DMT). It is used in ceremonial contexts for its visionary properties. The human pharmacology of ayahuasca has been well characterized following its administration in single doses.ObjectivesTo evaluate the human pharmacology of ayahuasca in repeated doses and assess the...

DOI: 10.1007/s00213-011-2434-x (opens in new tab) Ayahuasca Placebo Crossover study Pharmacology +3

Assessment of addiction severity among ritual users of ayahuasca

Drug and Alcohol Dependence June 17, 2010 Josep María Fábregas, Débora González, Sabela Fondevila et al. 228 citations

Ayahuasca is a psychoactive beverage used for magico-religious purposes in the Amazon. Recently, Brazilian syncretic churches have helped spread the ritual use of ayahuasca abroad. This trend has raised concerns that regular use of this N,N-dimethyltryptamine-containing tea may lead to the medical and psychosocial problems typically associated with drugs of abuse. Here we assess potential drug...

Daytime Ayahuasca administration modulates REM and slow-wave sleep in healthy volunteers

Psychopharmacology November 20, 2007 Manel J. Barbanoj, Jordi Riba, S. Clos et al. 74 citations

ObjectivesAyahuasca is a traditional South American psychoactive beverage and the central sacrament of Brazilian-based religious groups, with followers in Europe and the United States. The tea contains the psychedelic indole N,N-dimethyltryptamine (DMT) and beta-carboline alkaloids with monoamine oxidase-inhibiting properties that render DMT orally active. DMT interacts with serotonergic...

DOI: 10.1007/s00213-007-0963-0 (opens in new tab) Full text (opens in new tab) Ayahuasca Sleep system call Slow-wave sleep Behavioral sensitization +3

Pattern of use and subjective effects of Salvia divinorum among recreational users.

Drug and Alcohol Dependence November 8, 2006 Débora González, Jordi Riba, José Carlos Bouso et al. 163 citations

Salvia divinorum is a member of the Lamiaceae family and contains the psychotropic diterpene and kappa-opioid receptor agonist salvinorin-A. Originally a shamanic inebriant used by the Mexican Mazatec Indians, the plant and its preparations are becoming increasingly popular among non-traditional users. Demographic data and information on pattern of use and subjective effects were obtained by...

Increased frontal and paralimbic activation following ayahuasca, the pan-amazonian inebriant

Psychopharmacology March 30, 2006 Jordi Riba, Sergio Romero, Eva Grasa et al. 245 citations

RationaleAyahuasca is a South American psychoactive plant tea which contains the serotonergic psychedelic N,N-dimethyltryptamine (DMT) and monoamine-oxidase inhibitors that render DMT orally active. Previous investigations with ayahuasca have highlighted a psychotropic effect profile characterized by enhanced introspective attention, with individuals reporting altered somatic perceptions and...

Bringing Ayahuasca to the Clinical Research Laboratory

Journal of Psychoactive Drugs June 1, 2005 Jordi Riba, Manel J. Barbanoj 58 citations

Since the winter of 1999, the authors and their research team have been conducting clinical studies involving the administration of ayahuasca to healthy volunteers. The rationale for conducting this kind of research is twofold. First, the growing interest of many individuals for traditional indigenous practices involving the ingestion of natural psychotropic drugs such as ayahuasca demands the...

Effects of the South American Psychoactive Beverage Ayahuasca on Regional Brain Electrical Activity in Humans: A Functional Neuroimaging Study Using Low-Resolution Electromagnetic Tomography

Neuropsychobiology 2004 Jordi Riba, P. Anderer, F Jané et al. 131 citations

<i>Ayahuasca,</i> a South American psychotropic plant tea obtained from <i>Banisteriopsis caapi</i> and <i>Psychotria viridis</i>, combines monoamine oxidase-inhibiting β-carboline alkaloids with N,N-dimethyltryptamine (DMT), a psychedelic agent showing 5-HT<sub>2A</sub> agonist activity. In a clinical research setting, <i>ayahuasca</i> has demonstrated a combined stimulatory and psychedelic...

DOI: 10.1159/000077946 (opens in new tab) Ayahuasca Hallucinogen Electroencephalography Neuroimaging +1

Subject Index Vol. 50, 2004

Neuropsychobiology 2004 Nikolas Coupland, Tai-Jui Chen, Terence O'Donnell et al. 1 citation

event-related potentials 1, 167, 182 -evoked potentials 128, 288, 292 Autistic disorder 157 Averaged diffusion coefficient 119 'Ayahuasca' 89 Bipolar disorder 206, 239 ß-Carboline alkaloids/N,N-dimethyltryptamine ('ayahuasca') 89 Catechol-O-methyltransferase gene 153 Caudate nucleus 296 Cerebellar peduncle 119

DOI: 10.1159/000082147 (opens in new tab) Index typography Subject documents Library science World wide web

Human Pharmacology of Ayahuasca: Subjective and Cardiovascular Effects, Monoamine Metabolite Excretion, and Pharmacokinetics

Journal of Pharmacology and Experimental Therapeutics June 18, 2003 Jordi Riba, Marta Valle, Gloria Urbano et al. 383 citations

The effects of the South American psychotropic beverage ayahuasca on subjective and cardiovascular variables and urine monoamine metabolite excretion were evaluated, together with the drug's pharmacokinetic profile, in a double-blind placebo-controlled clinical trial. This pharmacologically complex tea, commonly obtained from Banisteriopsis caapi and Psychotria viridis, combines...

Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively

Psychopharmacology December 1, 2002 Jordi Riba, Antoni Rodrı́guez-fornells, Manel J. Barbanoj 71 citations

RationaleAyahuasca, a South American psychotropic plant tea, combines the psychedelic agent and 5-HT(2A/2C) agonist N, N-dimethyltryptamine (DMT) with beta-carboline alkaloids showing monoamine oxidase-inhibiting properties. Current human research with psychedelics and entactogens has explored the possibility that drugs displaying agonist activity at the 5-HT(2A/2C) sites temporally disrupt...

Topographic pharmaco‐EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers

British Journal of Clinical Pharmacology June 1, 2002 Jordi Riba, P. Anderer, Adelaida Morte et al. 126 citations

Aims Ayahuasca is a traditional South American psychoactive beverage used in Amazonian shamanism, and in the religious ceremonies of Brazilian‐based syncretic religious groups with followers in the US and several European countries. This tea contains measurable amounts of the psychotropic indole N , N ‐dimethyltryptamine (DMT), and β‐carboline alkaloids with MAO‐inhibiting properties. In a...

Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers

Psychopharmacology February 22, 2001 Jordi Riba, Antoni Rodrı́guez-fornells, Gloria Urbano et al. 302 citations

RationaleAyahuasca is a South American psychoactive beverage that contains the naturally occurring psychedelic agent N,N-dimethyltryptamine (DMT). This "tea" has been used for centuries in religious and medicinal contexts in the rain forest areas of South America and is presently gaining the attention of psychedelic users in North America and Europe.ObjectivesIn the present study, the...